Skip to main content
Clinical Trials/ISRCTN18116615
ISRCTN18116615
Completed
未知

A retrospective cross-sectional observational multi-centric study to evaluate the prevalence and distribution of steatotic and fibrotic liver disease across India via vibration-controlled transient elastography parameters

Zydus Healthcare Ltd0 sites13,750 target enrollmentAugust 6, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
on-alcoholic fatty liver disease (NAFLD)
Sponsor
Zydus Healthcare Ltd
Enrollment
13750
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 6, 2024
End Date
April 30, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>18 years
  • 2\. Patients who have given consent for the FIBROSCAN™ (VCTE) test

Exclusion Criteria

  • 1\. Pregnant or breastfeeding women
  • 2\. Individuals with alcohol consumption of more than 30 g and 20 g per day

Outcomes

Primary Outcomes

Not specified

Similar Trials